First Trade Date for Abgenix, Inc.
|Company Name||First Trade Date (yyyy-mm-dd)|
|History and Business of Company|
(this information may include date of incorporation)
Abgenix, Inc. (ABGX) is a biopharmaceutical company that develops and intends to commercialize antibody therapeutic products for the treatment of a variety of disease conditions, including transplant-related diseases, inflammatory and autoimmune disorders, cardiovascular disease, infectious diseases and cancer.|
The company has developed XenoMouse technology, a proprietary technology, which it believes offers many advantages over other antibody technologies, including rapid generation of highly specific, fully human antibody product candidates that bind to essentially any disease target appropriate for antibody therapy. The company believes its technology offers advantages in product development and flexibility in manufacturing. ABGX intends to use XenoMouse technology to build and commercialize a large and diversified product portfolio through the establishment of corporate collaborations and internal product development programs. Abgenix has collaborative arrangements with multiple pharmaceutical, biotechnology and genomics companies involving its XenoMouse technology. In December 1999, the company became the sole owner of the XenoMouse technology by acquiring all of the interest owned in the technology by JT America Inc.
In addition, ABGX has four proprietary antibody product candidates that are under development internally, three of which are in human clinical trials for graft-versus-host disease, psoriasis and cancer.
INCORPORATED in Delaware June 24, 1996 to succeed a business formed in 1989. OFFICE- 7601 Dumbarton Circle, Fremont, CA, USA 94555 (Tel.: 510-608-6500). Fax - 510-608-6511. WEBSITE- http://www.abgenix.com.
IMPORTANT DISCLAIMER: By reading any of the material on this website you agree to our DISCLAIMER: The Magi Society, The Magi Associates, Inc. and Magi Astrologers Worldwide Corporation make no claims whatsoever concerning the validity of the information provided herein, and will not be held liable for any use thereof. No information or opinion expressed here is a solicitation to buy or sell securities, bonds, real estate, commodities, options, futures or any financial instruments whatsoever.
Back to first trade date main page
Back to financial astrology page
Back to home page
© 1999-2004 by Magi Associates, Inc. and Magi Astrologers Worldwide Corporation. All Rights Reserved.
Magi Astrology is a trademark and service mark of THE MAGI ASSOCIATES, INC.